Evidence that genetic deletion of the TNF receptor p60 or p80 inhibits Fas mediated apoptosis in macrophages.
Almost 19 members of the tumor necrosis factor (TNF) superfamily have been identified that interact with 29 different receptors. Whether these receptors communicate with each other is not understood. Recently, we have shown that receptor activator of NF-kappaB ligand signaling is modulated by genetic deletion of the TNF receptor. In the current report, we investigated the possibility of a cross-talk between Fas and TNF-alpha signaling pathway in macrophage cell lines derived from wild-type (WT) mice and from mice with genetic deletion of the type 1 TNF receptor (p60(-/-)), the type 2 TNF receptor (p80(-/-)), or both receptors (p60(-/-)p80(-/-)). We found that the macrophages expressing TNF receptors were highly sensitive to apoptosis induced by anti-Fas. The genetic deletion of TNF receptors, however, made the cells resistance to anti-Fas-induced apoptosis. Anti-Fas induced activation of caspase-3 and PARP cleavage in WT cells but not in TNF receptor-deleted cells. This difference was found to be independent of the expression of Fas, Fas-associated protein with death domain (FADD) or TNF receptor-associated death domain (TRADD). We found that anti-Fas induced recruitment of TNFR1 into Fas-complex. We also found that TRADD, which mediates TNF signaling, was constitutively bound to Fas receptor in TNF receptor-deleted cells but not in wild-type cells. Transient transfection of TNFR1 in TNFR1-deleted cells sensitized them to anti-Fas-induced apoptosis. Overall our results demonstrate that Fas signaling is modulated by the TNF receptors and thus provide the evidence of cross-talk between the receptors of two cytokines.
Takada
Yasunari
Y
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Sung
Bokyung
B
Sethi
Gautam
G
Chaturvedi
Madan M
MM
Aggarwal
Bharat B
BB
D000818:Animals; D017209:Apoptosis; D002460:Cell Line; D017353:Gene Deletion; D008264:Macrophages / Q000166:cytology* / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000172:deficiency* / Q000235:genetics / Q000378:metabolism; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000235:genetics* / Q000378:metabolism; D019014:fas Receptor / Q000378:metabolism*
C491899:Fas protein, mouse; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; C506236:Tnfrsf1a protein, mouse; D019014:fas Receptor
J Biol Chem. 2004 Sep 17;279(38):39541-54
15252041
Blood. 2004 Dec 15;104(13):4113-21
15315973
Cell. 1993 May 7;73(3):457-67
8387893
Nature. 1994 Dec 8;372(6506):560-3
7990930
Cell. 1995 May 19;81(4):495-504
7758105
Cell. 1995 May 19;81(4):513-23
7538908
Blood. 1996 Feb 1;87(3):871-5
8562955
Cell. 1996 Jan 26;84(2):299-308
8565075
Immunity. 1996 Apr;4(4):387-96
8612133
Mol Cell Biol. 2000 Jul;20(13):4505-12
10848577
J Immunol. 2000 Nov 1;165(9):4814-21
11046004
J Biol Chem. 2001 Aug 24;276(34):31906-12
11438547
J Immunol. 2002 Dec 1;169(11):6490-7
12444159
J Biol Chem. 2003 Jun 27;278(26):23390-7
12695514
Cell Death Differ. 2003 Sep;10(9):997-1004
12934074
Nat Rev Immunol. 2003 Sep;3(9):745-56
12949498
J Immunol. 2003 Sep 15;171(6):3278-86
12960358
J Biol Chem. 2004 Feb 6;279(6):4750-9
14630924
J Exp Med. 1996 Mar 1;183(3):1271-5
8642271
J Biol Chem. 1996 Aug 16;271(33):19935-42
8702708
Nature. 1996 Nov 28;384(6607):372-5
8934525
J Biol Chem. 1997 Apr 11;272(15):9621-4
9092488
Br J Haematol. 1997 Dec;99(3):481-9
9401054
Eur J Immunol. 1998 Dec;28(12):4398-408
9862377
Annu Rev Immunol. 1999;17:331-67
10358762
J Exp Med. 1989 May 1;169(5):1747-56
2469768